{"log_id": 8758063652437859226, "direction": 0, "words_result_num": 59, "words_result": [{"probability": {"variance": 9e-06, "average": 0.997957, "min": 0.988072}, "location": {"width": 393, "top": 202, "height": 28, "left": 299}, "words": "由于老年人的生理功能下降,须慎重使用本药"}, {"probability": {"variance": 0.000328, "average": 0.990678, "min": 0.943112}, "location": {"width": 147, "top": 245, "height": 25, "left": 256}, "words": "【药物相互作用】"}, {"probability": {"variance": 0.000142, "average": 0.993179, "min": 0.941999}, "location": {"width": 394, "top": 283, "height": 27, "left": 298}, "words": "()药物合用的禁忌(本品不得与下列药物合用)"}, {"probability": {"variance": 0, "average": 0.999686, "min": 0.999665}, "location": {"width": 43, "top": 326, "height": 24, "left": 357}, "words": "药物"}, {"probability": {"variance": 0.001838, "average": 0.979831, "min": 0.868224}, "location": {"width": 159, "top": 324, "height": 26, "left": 577}, "words": "症状、体征和处理"}, {"probability": {"variance": 4e-05, "average": 0.990351, "min": 0.98264}, "location": {"width": 95, "top": 324, "height": 23, "left": 898}, "words": "机理和风险"}, {"probability": {"variance": 5e-06, "average": 0.998881, "min": 0.992774}, "location": {"width": 197, "top": 353, "height": 26, "left": 270}, "words": "氟尿嘧啶类抗肿瘤药"}, {"probability": {"variance": 0.000313, "average": 0.988115, "min": 0.928018}, "location": {"width": 535, "top": 359, "height": 51, "left": 277}, "words": "FU、UFT、替加氟、去合用该类药物(疗法)早期可导致严"}, {"probability": {"variance": 0.004742, "average": 0.979403, "min": 0.610671}, "location": {"width": 686, "top": 380, "height": 60, "left": 268}, "words": "氧氟尿苷:卡培他滨、卡重造血功能异常和腹泻、口腔炎等替吉奥胶囊"}, {"probability": {"variance": 8e-05, "average": 0.995385, "min": 0.960638}, "location": {"width": 562, "top": 416, "height": 28, "left": 506}, "words": "胃肠道反应。替吉奥胶囊停药至少7合并使用尿嘧或该类"}, {"probability": {"variance": 0.000262, "average": 0.993277, "min": 0.939838}, "location": {"width": 217, "top": 435, "height": 26, "left": 270}, "words": "莫氟;亚叶酸盐+UFT联"}, {"probability": {"variance": 0.006679, "average": 0.980834, "min": 0.564471}, "location": {"width": 573, "top": 443, "height": 30, "left": 506}, "words": "天内不得服用这些药物。若曾使用所产生的尿嘧啶的分解代谢"}, {"probability": {"variance": 0.007258, "average": 0.975433, "min": 0.557995}, "location": {"width": 836, "top": 460, "height": 40, "left": 269}, "words": "合疗法、左旋亚叶酸盐+过该类药物,为避免其影响,在替从而导氟尿嘧啶血药浓度明显"}, {"probability": {"variance": 3.2e-05, "average": 0.997373, "min": 0.982469}, "location": {"width": 159, "top": 489, "height": 24, "left": 271}, "words": "氟尿嘧啶联合疗法"}, {"probability": {"variance": 0.000448, "average": 0.99065, "min": 0.89605}, "location": {"width": 556, "top": 497, "height": 28, "left": 506}, "words": "吉奥胶囊开始给药前,须有适当的升高(详见【药代动力学】)"}, {"probability": {"variance": 1e-06, "average": 0.999164, "min": 0.997225}, "location": {"width": 201, "top": 516, "height": 24, "left": 271}, "words": "氟尿嘧啶类抗真菌药物"}, {"probability": {"variance": 4.3e-05, "average": 0.992109, "min": 0.983342}, "location": {"width": 62, "top": 529, "height": 23, "left": 506}, "words": "洗脱期"}, {"probability": {"variance": 3e-06, "average": 0.998466, "min": 0.995905}, "location": {"width": 78, "top": 546, "height": 24, "left": 271}, "words": "氟胞嘧啶"}, {"probability": {"variance": 5e-06, "average": 0.999006, "min": 0.990642}, "location": {"width": 305, "top": 583, "height": 25, "left": 505}, "words": "曾发现氟尿嘧啶类药物与抗病毒药"}, {"probability": {"variance": 9e-06, "average": 0.996951, "min": 0.990076}, "location": {"width": 278, "top": 568, "height": 25, "left": 827}, "words": "索利夫定和溴夫定的代谢产物溴"}, {"probability": {"variance": 0.001378, "average": 0.986178, "min": 0.811996}, "location": {"width": 838, "top": 593, "height": 46, "left": 269}, "words": "索利夫定及其结构类似物索利夫定或其结构类似物溴夫定乙烯基尿嘧啶(BVU)不可逆抑制"}, {"probability": {"variance": 1e-05, "average": 0.997983, "min": 0.98871}, "location": {"width": 258, "top": 622, "height": 26, "left": 845}, "words": "氢嘧啶脱氢酶,从而导致体内"}, {"probability": {"variance": 2.5e-05, "average": 0.993608, "min": 0.984656}, "location": {"width": 92, "top": 642, "height": 22, "left": 271}, "words": "物如溴夫定"}, {"probability": {"variance": 5e-06, "average": 0.997884, "min": 0.991898}, "location": {"width": 304, "top": 638, "height": 25, "left": 504}, "words": "联合使用时会导致严重造血功能障"}, {"probability": {"variance": 0.00181, "average": 0.986377, "min": 0.827489}, "location": {"width": 278, "top": 650, "height": 24, "left": 825}, "words": "替吉奥胶囊的代谢物5-FU的血"}, {"probability": {"variance": 2e-06, "average": 0.998368, "min": 0.995377}, "location": {"width": 234, "top": 667, "height": 23, "left": 506}, "words": "碍,部分患者可能危及生命"}, {"probability": {"variance": 0, "average": 0.999438, "min": 0.998161}, "location": {"width": 103, "top": 678, "height": 24, "left": 826}, "words": "药浓度升高"}, {"probability": {"variance": 8.6e-05, "average": 0.995257, "min": 0.964251}, "location": {"width": 470, "top": 706, "height": 27, "left": 299}, "words": "2)合并用药注意事项(该产品与下列药物合用时需注意"}, {"probability": {"variance": 0, "average": 0.999647, "min": 0.999405}, "location": {"width": 42, "top": 751, "height": 24, "left": 335}, "words": "药物"}, {"probability": {"variance": 2.3e-05, "average": 0.996098, "min": 0.986923}, "location": {"width": 160, "top": 748, "height": 26, "left": 559}, "words": "症状、体征和处理"}, {"probability": {"variance": 1.1e-05, "average": 0.997785, "min": 0.990002}, "location": {"width": 139, "top": 746, "height": 26, "left": 900}, "words": "机理和风险因素"}, {"probability": {"variance": 0.002449, "average": 0.986796, "min": 0.776999}, "location": {"width": 359, "top": 776, "height": 27, "left": 459}, "words": "可能发生苯妥英中毒(恶心、呕吐、眼球震"}, {"probability": {"variance": 9e-06, "average": 0.997898, "min": 0.987839}, "location": {"width": 267, "top": 788, "height": 26, "left": 836}, "words": "替加氟可抑制苯妥英的代谢,从"}, {"probability": {"variance": 8e-06, "average": 0.996742, "min": 0.992382}, "location": {"width": 82, "top": 806, "height": 25, "left": 273}, "words": "苯妥英类"}, {"probability": {"variance": 0.000253, "average": 0.994854, "min": 0.927942}, "location": {"width": 362, "top": 804, "height": 26, "left": 457}, "words": "颤和运动异常),须密切观察患者的一般状"}, {"probability": {"variance": 0.000245, "average": 0.99455, "min": 0.911836}, "location": {"width": 617, "top": 814, "height": 47, "left": 456}, "words": "况。如发现异常,须采取停药等相应措施。而导致苯妥英血药浓度升高"}, {"probability": {"variance": 1e-06, "average": 0.999327, "min": 0.997794}, "location": {"width": 362, "top": 860, "height": 25, "left": 458}, "words": "可能增强华法令钾的作用,须注意凝血功"}, {"probability": {"variance": 5e-06, "average": 0.996567, "min": 0.993053}, "location": {"width": 78, "top": 876, "height": 25, "left": 276}, "words": "华法令钾"}, {"probability": {"variance": 7e-06, "average": 0.997676, "min": 0.992471}, "location": {"width": 137, "top": 871, "height": 25, "left": 840}, "words": "其作用机理不明"}, {"probability": {"variance": 5e-06, "average": 0.9982, "min": 0.994405}, "location": {"width": 79, "top": 889, "height": 23, "left": 458}, "words": "能的变化"}, {"probability": {"variance": 1e-06, "average": 0.999186, "min": 0.997399}, "location": {"width": 361, "top": 912, "height": 28, "left": 458}, "words": "可能加重造血功能异常和胃肠道反应等不"}, {"probability": {"variance": 7e-06, "average": 0.998087, "min": 0.991368}, "location": {"width": 166, "top": 931, "height": 25, "left": 275}, "words": "其他的抗肿瘤药或"}, {"probability": {"variance": 0.002692, "average": 0.988936, "min": 0.714533}, "location": {"width": 575, "top": 939, "height": 30, "left": 458}, "words": "良反应,须密切观察患者的状况,如发现|相互之间加重不良反应"}, {"probability": {"variance": 0, "average": 0.9998, "min": 0.999594}, "location": {"width": 77, "top": 959, "height": 24, "left": 276}, "words": "放射治疗"}, {"probability": {"variance": 8e-06, "average": 0.998583, "min": 0.990983}, "location": {"width": 315, "top": 968, "height": 26, "left": 458}, "words": "异常,须采取减量或停药等相应措施"}, {"probability": {"variance": 9e-06, "average": 0.996932, "min": 0.992489}, "location": {"width": 108, "top": 1034, "height": 28, "left": 257}, "words": "【药物过量】"}, {"probability": {"variance": 2e-06, "average": 0.998734, "min": 0.994281}, "location": {"width": 475, "top": 1075, "height": 26, "left": 280}, "words": "旦发生药物过量,应密切监控,并进行支持、对症治疗。"}, {"probability": {"variance": 6e-06, "average": 0.996792, "min": 0.993538}, "location": {"width": 109, "top": 1118, "height": 25, "left": 266}, "words": "【临床试验】"}, {"probability": {"variance": 6e-06, "average": 0.998559, "min": 0.993214}, "location": {"width": 120, "top": 1160, "height": 24, "left": 299}, "words": "国外临床试验"}, {"probability": {"variance": 3e-06, "average": 0.9981, "min": 0.994767}, "location": {"width": 112, "top": 1201, "height": 24, "left": 277}, "words": "1)联合治疗"}, {"probability": {"variance": 0.000452, "average": 0.995047, "min": 0.863137}, "location": {"width": 814, "top": 1235, "height": 33, "left": 304}, "words": " PIRITS试验:在一项以305例日本晚期胃癌患者为对象,比较日本大鹏药业株式会社生产的替"}, {"probability": {"variance": 0.00469, "average": 0.983729, "min": 0.628436}, "location": {"width": 848, "top": 1276, "height": 33, "left": 261}, "words": "吉奥胶囊单药(以下简称单药组,连续28天口服替吉奥胶囊40~60mg/次,每日2次,每6周重复)"}, {"probability": {"variance": 0.001017, "average": 0.991642, "min": 0.808221}, "location": {"width": 858, "top": 1317, "height": 32, "left": 261}, "words": "和替吉奥胶囊联合顺铂治疗(以下简称联合治疗组,连续21天口服替吉奥胶囊40~60mg/次,每日2"}, {"probability": {"variance": 0.000197, "average": 0.995111, "min": 0.906538}, "location": {"width": 859, "top": 1356, "height": 36, "left": 259}, "words": "次,第8天时给予60mg/m2,每5周重复)的多中心Ⅲ期随机对照试验中,主要终点指标为总生存期"}, {"probability": {"variance": 0.004724, "average": 0.981129, "min": 0.653795}, "location": {"width": 844, "top": 1399, "height": 32, "left": 273}, "words": "OS),次要指标为无进展生存时间(PFS)和肿瘤缓解率。两组的患者基线特征是均衡可比。在分"}, {"probability": {"variance": 0.000215, "average": 0.994428, "min": 0.900556}, "location": {"width": 848, "top": 1438, "height": 35, "left": 269}, "words": "斤的298例患者中,联合治疗组(148例)和单药组(150例)中位生存时间分别为13个月和11个"}, {"probability": {"variance": 0.002838, "average": 0.970639, "min": 0.739757}, "location": {"width": 849, "top": 1481, "height": 33, "left": 260}, "words": "月,组间总生存期 Hazard比为0.77(95%置信区间0.61~0.98,Log-ank检验p=0.04),与单药组相比"}, {"probability": {"variance": 7.4e-05, "average": 0.994263, "min": 0.962397}, "location": {"width": 858, "top": 1521, "height": 35, "left": 259}, "words": "联合治疗可降低死亡风险约23%;两组中位PFS分别为6个月和4个月, Hazard比为0.57(95%置信"}, {"probability": {"variance": 0.00791, "average": 0.95294, "min": 0.522023}, "location": {"width": 858, "top": 1563, "height": 35, "left": 258}, "words": "区间0.4~0.73,Log-rank检验p0.001),与对照组相比,本品/顺铂联合化疗可降低复发风险约43"}], "language": 3}